Ignite Creation Date:
2024-05-05 @ 5:26 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00452725
Status:
COMPLETED
Last Update Posted:
2010-10-05
First Post:
2007-03-23
Brief Title:
Effect of MAXOMAT on the Growth of Small Children to NOONANs Syndrome
Sponsor:
Sanofi
Organization:
Sanofi
Study Overview
Official Title:
Effect of the Growth Hormone MAXOMAT on the Growth of Small Children and Adolescents -2 SD Due to NOONANs Syndrome
Status:
COMPLETED
Status Verified Date:
2010-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
1 Clinical Objective To improve the growth of these children
2 Genetic objective A study of the genetics of the syndrome
2 Genetic objective A study of the genetics of the syndrome
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None